3Clinical and Laboratory Standards Institute(CLSI).Performance Standards for Antimicrobial susceptibility Testing;Nineteenth Informational Supplement[S].CLSI,2009,M100-S19:65. 被引量：1
4WHO. Pneumococcal conjugate vaccine for childhood immunization--WHO position paper[J]. Wkly Epidemiol Rec, 2007, 82(12): 93-104. 被引量：1
5Siira L, Jalava J, Tissari P, et al. Clonality behind the increase of multidrug-resistance among non-invasive pneumococci in Southern Finland[J]. Eur J Clin Microbiol Infect Dis, 2012, 31(5): 867-871. 被引量：1
6Li C F, Liu M F, Shi Z Y, et al. Changing trends in antimierobial susceptibility of Streptococcus pneumoniae isolates in Taiwan, 2006--2007[J]. J Microbiol Immunol Infect, 2012, 45(4): 305-310. 被引量：1
7Wierzbowski A K, Karlowsky J A, Adam H J, et al. Evolution and molecular characterization ofmacrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008[J]. JAntimicrob Chemother, 2014, 69(1): 59-66. 被引量：1
8Jones R N, Sader H S, Mendes R E, et al. Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998--2011 ) [J]. Diagn Microbiol Infect Dis, 2013, 75(1): 107-109. 被引量：1
10Geng Q, Zhang T, Ding Y F, et al. Molecular characterization and antimicrobial susceptibility of Streptococcus pneumoniae isolated from Children Hospitalized with Respiratory Infectionsin Suzhou, China[J]. PLoS One, 2014, 9(4): e93752. 被引量：1
